Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy

Critical Care Medicine

Volumn 30, Issue 5 SUPPL., 2002, Pages

  Harlan, John M ^a   Winn, Robert K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adhesion; Endothelial; Ischemia; Leukocyte; Reperfusion; Shock

Indexed keywords

CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY;

BLOOD VESSEL INJURY; CELL ADHESION; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONFERENCE PAPER; ENTERITIS; HEART INFARCTION; HEMORRHAGIC SHOCK; HUMAN; IMMUNOPATHOLOGY; ISCHEMIA; LEUKOCYTE ADHERENCE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PSORIASIS; REPERFUSION; STROKE; TISSUE INJURY; TRAUMATIC SHOCK;

EID: 0036254688     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200205001-00007     Document Type: Conference Paper

References (59)

1. Leukocyte-endothelial adhesion molecules
2. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
3. Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration
4. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP
5. PECAM-1 is required for transendothelial migration of leukocytes
6. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells
7. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow
8. Divergent fates of P- and E-selectins after their expression on the plasma membrane
9. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors
10. Nitric oxide: An endogenous modulator of leukocyte adhesion
11. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium
12. Of man and mouse: Leukocyte and endothelial adhesion molecule deficiencies
13. Selectins and neutrophil traffic: Margination and Streptococcus pneumoniae-induced emigration in murine lungs
14. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature
15. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1
16. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: A novel lymphocyte-endothelial cell primary adhesion pathway
17. VAP-1: An adhesin and an enzyme
18. CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits
19. Differential effects of CD18, CD29, and CD49 integrin subunit inhibition on neutrophil migration in pulmonary inflammation
20. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway
21. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms
22. Platelet-endothelium interactions
23. Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions
24. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIb-beta3 and stimulated by platelet-activating factor
25. Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model
26. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets
27. Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice
28. Adhesion of activated platelets to venous endothelial cells is mediated via GPIIb/IIIa
29. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin
30. Platelet-endothelial interactions in inflamed mesenteric venules
31. Platelet-endothelial cell interactions during ischemia/reperfusion: The role of P-selectin
32. Adhesion of activated platelets to endothelial cells: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha
33. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production
34. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
35. Anti-adhesion therapy
36. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients
37. Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial
38. A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis
39. A small-molecule, tight-binding inhibitor of the integrin alpha(4)beta(1) blocks antigen-induced airway responses and inflammation in experimental asthma in sheep
40. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
41. Absence of efficacy of subcutaneous anti-sense ICAM-1 treatment of chronic active Crohn's disease
42. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
43. Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis
44. Blockade of CD49d (alpha(4) integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma
45. The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury
46. Adhesion molecules and hemorrhagic shock
47. CD18 trials disappoint again
48. Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: Results of a phase II clinical trial
49. Immunomodulators: Inhibitors of adhesion
50. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice
51. Factors modifying protective effect of anti-CD18 antibodies on myocardial reperfusion injury in dogs
52. The effect of a CD11/CD18 inhibitor (HU23F2G) on infarct size following direct angioplasty: The halt MI study
53. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy